About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Rbpjtm1Hon
targeted mutation 1, Tasuku Honjo
MGI:3583755
Summary 32 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Rbpjtm1Hon/Rbpjtm1Hon involves: 129P2/OlaHsd * C57BL/6 MGI:2654059
cn2
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+
Rbpjtm1Hon/Rbpjtm1Hon
Tg(tetO-cre)1Jaw/0
involves: 129 * C57BL/6 MGI:4418250
cn3
Pax3tm1(cre)Joe/Pax3+
Rbpjtm1Hon/Rbpjtm1Hon
involves: 129P2/OlaHsd MGI:3706969
cn4
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Lbx1-cre)3Cbm/0
involves: 129P2/OlaHsd MGI:3706967
cn5
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Pax2-cre)1Akg/0
involves: 129P2/OlaHsd MGI:3713804
cn6
Rbpjtm1Hon/Rbpjtm1.1Hon
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Ptf1atm2(cre/ESR1)Cvw/Ptf1a+
involves: 129P2/OlaHsd * 129S1/Sv * 129S6/SvEvTac MGI:5310800
cn7
Pgrtm2(cre)Lyd/Pgr+
Rbpjtm1Hon/Rbpjtm1Hon
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ MGI:7333164
cn8
Rbpjtm1Hon/Rbpjtm1.1Hon
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Hes1tm1(cre/ERT2)Lcm/Hes1+
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ MGI:5310799
cn9
Gt(ROSA)26Sortm1(Notch1)Dam/Gt(ROSA)26Sor+
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Col1a1-cre)1Kry/0
involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * FVB/N MGI:5883005
cn10
Rbpjtm1Hon/Rbpjtm1.1Hon
Shhtm2(cre/ERT2)Cjt/Shh+
involves: 129P2/OlaHsd * 129S6/SvEvTac MGI:4948663
cn11
Rbpjtm1Hon/Rbpjtm1.1Hon
Tg(Pax7-cre/ERT2)1Cbm/0
involves: 129P2/OlaHsd * BALB/cJ MGI:3807512
cn12
Rbpjtm1Kyo/Rbpjtm1Hon
Tg(Tek-cre)12Flv/0
involves: 129P2/OlaHsd * C3H * C57BL/6 MGI:3056465
cn13
Mesp1tm2(cre)Ysa/Mesp1+
Rbpjtm1Hon/Rbpjtm1Hon
Tg(CAG-cat,-Notch1)1Ysa/0
involves: 129P2/OlaHsd * C3H * C57BL/6 * CBA MGI:3808717
cn14
Rbpjtm1Hon/Rbpjtm1Hon
Commd10Tg(Vav1-icre)A2Kio/Commd10+
involves: 129P2/OlaHsd * C57BL/10 * CBA/Ca MGI:4821304
cn15
Cd19tm1(cre)Cgn/Cd19+
Rbpjtm1Hon/Rbpjtm1Hon
involves: 129P2/OlaHsd * C57BL/6 MGI:2654061
cn16
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Itgax-cre)1-1Reiz/0
involves: 129P2/OlaHsd * C57BL/6 * CBA MGI:3763283
cn17
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Nes-cre)1Wme/0
involves: 129P2/OlaHsd * C57BL/6 * CBA MGI:2654079
cn18
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Cyp1a1-cre)1Dwi/0
involves: 129P2/OlaHsd * C57BL/6 * CBA MGI:3603009
cn19
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Mx1-cre)1Cgn/0
involves: 129P2/OlaHsd * C57BL/6 * CBA MGI:3603011
cn20
Cd19tm1(cre)Cgn/Cd19+
Rbpjtm1Hon/Rbpjtm1Hon
Spentm2.1Hon/Spentm2.1Hon
involves: 129P2/OlaHsd * C57BL/6 * CBA MGI:3710554
cn21
Rbpjtm1Hon/Rbpjtm1Hon
Mesp1tm2(cre)Ysa/Mesp1+
involves: 129P2/OlaHsd * C57BL/6 * CBA MGI:3808716
cn22
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Cd4-cre)1Cwi/?
involves: 129P2/OlaHsd * C57BL/6 * DBA MGI:3844285
cn23
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Lck-cre)19Hhan/0
involves: 129P2/OlaHsd * C57BL/6 * DBA MGI:4889050
cn24
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Tyr-cre)2Lru/0
involves: 129P2/OlaHsd * C57BL/6 * DBA/2 MGI:3758749
cn25
Rbpjtm1Hon/Rbpj+
Tg(Tyr-cre)2Lru/0
involves: 129P2/OlaHsd * C57BL/6 * DBA/2 MGI:3758750
cn26
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Tyr-cre)#Lru/0
involves: 129P2/OlaHsd * C57BL/6 * DBA/2 MGI:6267333
cn27
Fbxw7tm1Kei/Fbxw7tm1Kei
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Cd4-cre)1Cwi/?
involves: 129P2/OlaHsd * C57BL/6 * DBA/2 MGI:3767598
cn28
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Vil1-cre/ERT2)23Syr/0
involves: 129P2/OlaHsd * C57BL/6 * DBA/2 MGI:3603010
cn29
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Col1a1-cre)1Kry/0
involves: 129P2/OlaHsd * C57BL/6 * FVB/N MGI:5882984
cn30
Rbpjtm1Hon/Rbpjtm1Hon
Tg(MMTV-cre)1Mam/0
involves: 129P2/OlaHsd * C57BL/6J * FVB * SJL MGI:3653205
cn31
Nr2f2tm2.1Tsa/Nr2f2tm2.1Tsa
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Tek-cre)1Ywa/0
involves: 129S1/Sv * 129S7/SvEvBrd * C57BL/6 * SJL MGI:4441397
cn32
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Tek-cre)1Ywa/0
involves: 129S7/SvEvBrd * C57BL/6 * SJL MGI:4441396


Genotype
MGI:2654059
hm1
Allelic
Composition
Rbpjtm1Hon/Rbpjtm1Hon
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rbpjtm1Hon mutation (2 available); any Rbpj mutation (193 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
N
• normal B cell development




Genotype
MGI:4418250
cn2
Allelic
Composition
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+
Rbpjtm1Hon/Rbpjtm1Hon
Tg(tetO-cre)1Jaw/0
Genetic
Background
involves: 129 * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy mutation (5 available); any Gt(ROSA)26Sor mutation (935 available)
Rbpjtm1Hon mutation (2 available); any Rbpj mutation (193 available)
Tg(tetO-cre)1Jaw mutation (5 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• doxycycline-treated mice die shortly after birth

respiratory system
• at E18.5, myofibroblasts in the lungs of doxycycline-treated mice exhibit reduced differentiation, as determined by sma+ expression, compared to in wild-type mice




Genotype
MGI:3706969
cn3
Allelic
Composition
Pax3tm1(cre)Joe/Pax3+
Rbpjtm1Hon/Rbpjtm1Hon
Genetic
Background
involves: 129P2/OlaHsd
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Pax3tm1(cre)Joe mutation (1 available); any Pax3 mutation (50 available)
Rbpjtm1Hon mutation (2 available); any Rbpj mutation (193 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• expected Mendelian ratios are born but homozygous mice do not move or breath and die shortly after birth

muscle
• at E11.5, progenitor cell numbers in the myotome are decreased and the number of differentiated cells is increased compared to wild-type
• at E14.5 residual back muscles are small and lack progenitor cells
• limb muscles have reduced myogenic precursor cells and lack satellite cells
• diaphragm is smaller
• intercostal muscles are small
• at E14.5, the size of limb muscle groups is reduced
• absence of satellite cells in limb, intercostals, diaphragm and deep back muscles

respiratory system

behavior/neurological
• no movement at birth

nervous system
• at E10.5 and E11.5, mice exhibit precocious neuronal differentiation compared to in wild-type mice
• overall neurogenesis is increased in the dorsal spinal cord
• the numbers of dI2 and dI3 neurons are increased slightly while the number of dI5 neurons is increased dramatically compared to in wild-type mice
• the dorsal neural tube in E10.5 embyros lacks dI4 neurons with the number of dI2, dI3, and dI5 neurons being increased
• the number of dI5 neurons is dramatically increased while increases in dI2 and dI3 neurons are more modest
• there is a significant decrease in the thickness of the progenitor domain of the E11.5 neural tube and a corresponding increase in the neuronal domain
• the dorsal progenitor domain of the neural tube is depleted by E12
• mice exhibit a reduction in the number of dI4 neurons compared to in wild-type mice
• the numbers of dI3 neurons are increased slightly compared to in wild-type mice
• the progenitor domain is reduced compared to in wild-type mice
• mice exhibit a complete loss of dI4 interneurons

embryo
• the dorsal neural tube in E10.5 embyros lacks dI4 neurons with the number of dI2, dI3, and dI5 neurons being increased
• the number of dI5 neurons is dramatically increased while increases in dI2 and dI3 neurons are more modest
• there is a significant decrease in the thickness of the progenitor domain of the E11.5 neural tube and a corresponding increase in the neuronal domain
• the dorsal progenitor domain of the neural tube is depleted by E12

cellular
• at E10.5 and E11.5, mice exhibit precocious neuronal differentiation compared to in wild-type mice
• overall neurogenesis is increased in the dorsal spinal cord
• the numbers of dI2 and dI3 neurons are increased slightly while the number of dI5 neurons is increased dramatically compared to in wild-type mice




Genotype
MGI:3706967
cn4
Allelic
Composition
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Lbx1-cre)3Cbm/0
Genetic
Background
involves: 129P2/OlaHsd
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rbpjtm1Hon mutation (2 available); any Rbpj mutation (193 available)
Tg(Lbx1-cre)3Cbm mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• expected Mendelian ratios of mice are born but homozygotes fail to suckle and subsequently die within the first postnatal day

muscle
• at E11.5, more progenitor cells have started to differentiate (indicated by increased Myod expression)
• at E12.5 in the limbs, more cells express markers of myogenic differentiation and fewer progenitor cells remain
• at E14.5 in the limbs, fewer muscle progenitor cells are present and those present have reduced proliferative capacity
• at E18.5 all cells are postmitotic unlike in wild-type
• however, the muscle progenitor cells migration is unaffected
• at E14.5 there is a reduction in the size of limb muscle groups
• absence of satellite cells in limb muscle at E18.5
• very few satellite cells are seen in intrinsic tongue muscle at E14.5 however, satellite cells can be detected in the distal forelimb
• muscle fibers in limb muscle have reduced density and the ratio of Myod+ nuclei/fiber is reduced
• however, myofiber diameter is comparable to wild-type

behavior/neurological
• homozygotes fail to suckle




Genotype
MGI:3713804
cn5
Allelic
Composition
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Pax2-cre)1Akg/0
Genetic
Background
involves: 129P2/OlaHsd
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rbpjtm1Hon mutation (2 available); any Rbpj mutation (193 available)
Tg(Pax2-cre)1Akg mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• embryos are normal at E12.5, but die at E13.5

renal/urinary system
• podocytes with WT1high expression do not develop in E12.5 cultures
• cultured E12.5 mtanephroi branch normally, but tubules positive for LTL (lectin) are not detected




Genotype
MGI:5310800
cn6
Allelic
Composition
Rbpjtm1Hon/Rbpjtm1.1Hon
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Ptf1atm2(cre/ESR1)Cvw/Ptf1a+
Genetic
Background
involves: 129P2/OlaHsd * 129S1/Sv * 129S6/SvEvTac
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm1(EYFP)Cos mutation (11 available); any Gt(ROSA)26Sor mutation (935 available)
Ptf1atm2(cre/ESR1)Cvw mutation (3 available); any Ptf1a mutation (30 available)
Rbpjtm1.1Hon mutation (1 available); any Rbpj mutation (193 available)
Rbpjtm1Hon mutation (2 available); any Rbpj mutation (193 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
N
• tamoxifen-treated mice exhibit normal proliferation of YFP+ acinar cells




Genotype
MGI:7333164
cn7
Allelic
Composition
Pgrtm2(cre)Lyd/Pgr+
Rbpjtm1Hon/Rbpjtm1Hon
Genetic
Background
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Pgrtm2(cre)Lyd mutation (0 available); any Pgr mutation (73 available)
Rbpjtm1Hon mutation (2 available); any Rbpj mutation (193 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
embryo
• following induction of in vivo artificial decidualization (AD), mice show a reduced decidual response on both 3 and 5 days after AD (AD3 and AD5) based on stimulated to unstimulated uterine horn weight ratio
• on AD5, impaired decidualization is associated with decreased uterine mRNA expression of decidual markers (Bmp2 and Wnt4) and reduced progesterone receptor (Pgr) signaling in the stimulated horn relative to control mice
• consistent with a trend towards decreased mRNA expression of glucose transporter Slc2a1, protein localization SLC2A1 is significantly reduced in the decidual horn esp. within the secondary decidual zone

reproductive system
• following induction of in vivo artificial decidualization (AD), mice show a reduced decidual response on both 3 and 5 days after AD (AD3 and AD5) based on stimulated to unstimulated uterine horn weight ratio
• on AD5, impaired decidualization is associated with decreased uterine mRNA expression of decidual markers (Bmp2 and Wnt4) and reduced progesterone receptor (Pgr) signaling in the stimulated horn relative to control mice
• consistent with a trend towards decreased mRNA expression of glucose transporter Slc2a1, protein localization SLC2A1 is significantly reduced in the decidual horn esp. within the secondary decidual zone




Genotype
MGI:5310799
cn8
Allelic
Composition
Rbpjtm1Hon/Rbpjtm1.1Hon
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Hes1tm1(cre/ERT2)Lcm/Hes1+
Genetic
Background
involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm1(EYFP)Cos mutation (11 available); any Gt(ROSA)26Sor mutation (935 available)
Hes1tm1(cre/ERT2)Lcm mutation (0 available); any Hes1 mutation (21 available)
Rbpjtm1.1Hon mutation (1 available); any Rbpj mutation (193 available)
Rbpjtm1Hon mutation (2 available); any Rbpj mutation (193 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
N
• tamoxifen-treated mice exhibit normal pancreatic ductal morphology and pancreata mass
• tamoxifen-treated mice exhibit a decrease in YFP+ centroacinar cells compared with control mice
• tamoxifen-treated mice exhibit an increase in YFP+ acinar cells compared with control mice
• tamoxifen-treated mice exhibit a rapid transformation of YFP+ centroacinar cells into acinar cells compared with control mice
• however, tamoxifen-treated mice exhibit normal centroacinar and acinar cells proliferation and apoptosis

digestive/alimentary system
• tamoxifen-treated mice exhibit a decrease in YFP+ centroacinar cells compared with control mice
• tamoxifen-treated mice exhibit an increase in YFP+ acinar cells compared with control mice




Genotype
MGI:5883005
cn9
Allelic
Composition
Gt(ROSA)26Sortm1(Notch1)Dam/Gt(ROSA)26Sor+
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Col1a1-cre)1Kry/0
Genetic
Background
involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm1(Notch1)Dam mutation (1 available); any Gt(ROSA)26Sor mutation (935 available)
Rbpjtm1Hon mutation (2 available); any Rbpj mutation (193 available)
Tg(Col1a1-cre)1Kry mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
skeleton
N
• mice exhibit rescue of growth retardation and osteosclerotic phenotypes seen in single Gt(ROSA)26Sortm1(Notch1)Dam conditional mice




Genotype
MGI:4948663
cn10
Allelic
Composition
Rbpjtm1Hon/Rbpjtm1.1Hon
Shhtm2(cre/ERT2)Cjt/Shh+
Genetic
Background
involves: 129P2/OlaHsd * 129S6/SvEvTac
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rbpjtm1.1Hon mutation (1 available); any Rbpj mutation (193 available)
Rbpjtm1Hon mutation (2 available); any Rbpj mutation (193 available)
Shhtm2(cre/ERT2)Cjt mutation (1 available); any Shh mutation (45 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
respiratory system
• at E18.5, the respiratory epithelium was populated almost exclusively by Foxj1-expressing ciliated cells, unlike in control lungs where ciliated cells were interspersed with secretory Clara cells
• at E18.5, Ki67 labeling was dramatically reduced in large, medium and small airways, suggesting a severe decrease in epithelial cell proliferation relative to control lungs
• however, goblet cell fate was not lost, as shown by PAS and Alcian Blue staining of tracheal sections at birth (P0)
• no secretory Clara cells were detected at E18.5, as determined by specific marker analysis




Genotype
MGI:3807512
cn11
Allelic
Composition
Rbpjtm1Hon/Rbpjtm1.1Hon
Tg(Pax7-cre/ERT2)1Cbm/0
Genetic
Background
involves: 129P2/OlaHsd * BALB/cJ
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rbpjtm1.1Hon mutation (1 available); any Rbpj mutation (193 available)
Rbpjtm1Hon mutation (2 available); any Rbpj mutation (193 available)
Tg(Pax7-cre/ERT2)1Cbm mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• following treatment with tamoxifen, mice exhibit a reduction in the number of dILA neurons and an increased in the number of dILB neurons compared to in wild-type mice
• there is a decrease in the thickness of the progenitor zone in the neural tube of E13.5 embryos when tamoxifen is given at E10.5
• tamoxifen induction at E10.5 leads to about a 50% reduction in dILA neurons in newborns and about a 50% increase in dILB neurons
• following treatment with tamoxifen, mice exhibit a reduction in the number of dILA neurons compared to in wild-type mice
• following treatment with tamoxifen, mice exhibit an increased in the number of dILB neurons compared to in wild-type mice
• at E13.5 following treatment with tamoxifen, the progenitor domain is reduced compared to in wild-type mice

embryo
• there is a decrease in the thickness of the progenitor zone in the neural tube of E13.5 embryos when tamoxifen is given at E10.5
• tamoxifen induction at E10.5 leads to about a 50% reduction in dILA neurons in newborns and about a 50% increase in dILB neurons

cellular
• following treatment with tamoxifen, mice exhibit a reduction in the number of dILA neurons and an increased in the number of dILB neurons compared to in wild-type mice




Genotype
MGI:3056465
cn12
Allelic
Composition
Rbpjtm1Kyo/Rbpjtm1Hon
Tg(Tek-cre)12Flv/0
Genetic
Background
involves: 129P2/OlaHsd * C3H * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rbpjtm1Hon mutation (2 available); any Rbpj mutation (193 available)
Rbpjtm1Kyo mutation (1 available); any Rbpj mutation (193 available)
Tg(Tek-cre)12Flv mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cardiovascular system
• the diameter of the dorsal aorta is reduced at E9.5
• at E9.5 PECAM-1 staining revealed a complete lack of vascular remodeling
• the distal outflow tract is connected to the anterior cardinal vein by an anastamoses
• some embryos also have more caudal fusions of the dorsal aorta to the common cardinal vein
• an avascular yolk is seen at E9.5
• pericardial effusion is seen at E9.5

embryo
• an avascular yolk is seen at E9.5
• embryonic growth retardation is seen at E9.5

growth/size/body
• embryonic growth retardation is seen at E9.5

homeostasis/metabolism
• pericardial effusion is seen at E9.5

cellular
• at E9.5 PECAM-1 staining revealed a complete lack of vascular remodeling




Genotype
MGI:3808717
cn13
Allelic
Composition
Mesp1tm2(cre)Ysa/Mesp1+
Rbpjtm1Hon/Rbpjtm1Hon
Tg(CAG-cat,-Notch1)1Ysa/0
Genetic
Background
involves: 129P2/OlaHsd * C3H * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mesp1tm2(cre)Ysa mutation (1 available); any Mesp1 mutation (17 available)
Rbpjtm1Hon mutation (2 available); any Rbpj mutation (193 available)
Tg(CAG-cat,-Notch1)1Ysa mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cardiovascular system
• defects in heart morphology and development are unaffected by the presence of the transgene
• defects in heart morphology and development are unaffected by the presence of the transgene




Genotype
MGI:4821304
cn14
Allelic
Composition
Rbpjtm1Hon/Rbpjtm1Hon
Commd10Tg(Vav1-icre)A2Kio/Commd10+
Genetic
Background
involves: 129P2/OlaHsd * C57BL/10 * CBA/Ca
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Commd10Tg(Vav1-icre)A2Kio mutation (2 available); any Commd10 mutation (23 available)
Rbpjtm1Hon mutation (2 available); any Rbpj mutation (193 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• transplanted bone marrow progenitors transfected with BCR-ABL and NUP98-HOXA9 proliferate slower than similarly treated wild-type cells improving host survival




Genotype
MGI:2654061
cn15
Allelic
Composition
Cd19tm1(cre)Cgn/Cd19+
Rbpjtm1Hon/Rbpjtm1Hon
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd19tm1(cre)Cgn mutation (11 available); any Cd19 mutation (56 available)
Rbpjtm1Hon mutation (2 available); any Rbpj mutation (193 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• mutants show high sensitivity to the lethal effects of blood-borne Staphylococcus aureus infection

immune system
• affected differentiation of T2 B cells, indicated by a reduced population of marginal zone B (MZB) cells and an increased population of follicular B cells
• loss of marginal zone B cells (J:76240)
• decreased numbers of marginal zone B cells (J:121523)
• increased numbers of follicular B cells in spleen (J:121523)
• 3-fold increase in serum IgG3
• increased mortality rate after blood-born bacterial infection
• mutants show high sensitivity to the lethal effects of blood-borne Staphylococcus aureus infection

hematopoietic system
• affected differentiation of T2 B cells, indicated by a reduced population of marginal zone B (MZB) cells and an increased population of follicular B cells
• loss of marginal zone B cells (J:76240)
• decreased numbers of marginal zone B cells (J:121523)
• increased numbers of follicular B cells in spleen (J:121523)
• 3-fold increase in serum IgG3




Genotype
MGI:3763283
cn16
Allelic
Composition
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Itgax-cre)1-1Reiz/0
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rbpjtm1Hon mutation (2 available); any Rbpj mutation (193 available)
Tg(Itgax-cre)1-1Reiz mutation (4 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
• splenic dendritic cell (DC) population is decreased similarly to bone marrow deletion of Rbpj; ratio of CD8-/CD8+ dendritic cells is significantly decreased, resulting from 3-fold decrease in numbers of CD8- DCs with normal numbers of CD8+ DCs
• frequency of cytokine-secreting CD8- DCs in cultured splenocytes is decreased 3-fold compared to controls whereas cytokine-secreting CD8+ DCs is unchanged

immune system
• splenic dendritic cell (DC) population is decreased similarly to bone marrow deletion of Rbpj; ratio of CD8-/CD8+ dendritic cells is significantly decreased, resulting from 3-fold decrease in numbers of CD8- DCs with normal numbers of CD8+ DCs
• frequency of cytokine-secreting CD8- DCs in cultured splenocytes is decreased 3-fold compared to controls whereas cytokine-secreting CD8+ DCs is unchanged
• in response to TLR activation, dendritic cell cytokine production is decreased compared to controls




Genotype
MGI:2654079
cn17
Allelic
Composition
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Nes-cre)1Wme/0
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rbpjtm1Hon mutation (2 available); any Rbpj mutation (193 available)
Tg(Nes-cre)1Wme mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cellular
• cysts result from aberrant fate determination of stem cells to epidermal progenitors and their accelerated differentiation into epidermis

integument
• cysts in the dermal layer but not in the epidermis, close to hair follicles, frequently in the vibrissa region
• cysts are composed of epidermal cells aberrantly differentiated from mutant hair follicular stem cells
• cyst formation occurs after hair loss or after the first hair cycle
• begin to lose hair 1-3 months after birth, when the first or second hair cycle terminates
• hair loss frequently occurs in the vibrissa region
• hyperkeratinization of the epidermis on the back and tail
• epidermis is thickened in some regions

growth/size/body
• cysts in the dermal layer but not in the epidermis, close to hair follicles, frequently in the vibrissa region
• cysts are composed of epidermal cells aberrantly differentiated from mutant hair follicular stem cells
• cyst formation occurs after hair loss or after the first hair cycle




Genotype
MGI:3603009
cn18
Allelic
Composition
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Cyp1a1-cre)1Dwi/0
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rbpjtm1Hon mutation (2 available); any Rbpj mutation (193 available)
Tg(Cyp1a1-cre)1Dwi mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
digestive/alimentary system
• 3 and 5 days after injection with beta-naphthoflavone the number of goblet cells is increased in the small intestine and colon
• 5 days after injection with beta-naphthoflavone, essentially all epithelial cell division has stopped in the small intestine and colon, but no significant increase in apoptosis is seen
• 5 days after injection with beta-naphthoflavone, in the small intestine and colon the rapidly dividing transit amplifying compartment is completely replaced by post-mitotic goblet cells
• however, in the small intestine Paneth cell morphology is normal

endocrine/exocrine glands
• 5 days after injection with beta-naphthoflavone, in the small intestine and colon the rapidly dividing transit amplifying compartment is completely replaced by post-mitotic goblet cells
• however, in the small intestine Paneth cell morphology is normal

cellular
• 3 and 5 days after injection with beta-naphthoflavone the number of goblet cells is increased in the small intestine and colon




Genotype
MGI:3603011
cn19
Allelic
Composition
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Mx1-cre)1Cgn/0
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rbpjtm1Hon mutation (2 available); any Rbpj mutation (193 available)
Tg(Mx1-cre)1Cgn mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• 1 and 3 months after poly(I)-poly(C) injection, thymus size is reduced
• 1 month after poly(I)-poly(C) injection, the number of thymocytes is reduced and by 3 months the number of thymocytes is reduced to 1/8 that in control mice
• 1 and 3 months after poly(I)-poly(C) injection, in the thymus and bone marrow lymphocyte progenitors induce B cell development at the expense of T cell development; however myeloid and B cell lineage development in the bone marrow is normal
• after poly(I)-poly(C) injection, B cell development is impaired in the spleen but not in the bone marrow
• 1 and 3 months after poly(I)-poly(C) injection, a progressive increase in the number of double negative cells is seen in the thymus; however many of these cells are B cells
• 1 and 3 months after poly(I)-poly(C) injection, a progressive decrease in the number of double positive cells is seen in the thymus
• 1 and 3 months after poly(I)-poly(C) injection, T cell development is arrested at the CD44+CD25- pro-T cell or earlier stage (J:99747)
• 3 weeks after induction of cre expression by poly(I):poly(C) treatment, mice manifest a block in T cell development in the thymus (J:125869)
• 3 weeks after induction of cre expression by poly(I):poly(C) treatment, fraction of PDCs is elevated in the spleen
• 3 weeks after induction of cre expression by poly(I):poly(C) treatment, proportion of conventional Cd11chigh MHC class II+ dendritic cells is reduced 2.5 fold; decrease in the fraction of Cd11b+ dendritic cells corresponding to the CD8- subset is consistently observed
• one month after IFN-induced deletion, mutants show a gradual deletion of marginal zone B cells, from 10% to 3% of splenic B cells (J:76240)
• after poly(I)-poly(C) injection, marginal zone B cells are drastically reduced in spleen (J:99747)
• 1 and 3 months after poly(I)-poly(C) injection, a progressive increase in the number of B cells is seen in the thymus (J:99747)
• after poly(I)-poly(C) injection, pro-B and pre-B cell numbers are increased in the thymus (J:99747)
• 3 weeks after induction of cre expression by poly(I):poly(C) treatment, increased B cell development in the thymus is observed (J:125869)
• after poly(I)-poly(C) injection, follicular B cells are slightly increased in spleen
• 1 and 3 months after poly(I)-poly(C) injection, a progressive decrease in the number of single positive cells is seen in the thymus
• 3 weeks after induction of cre expression by poly(I):poly(C) treatment, fraction of Cd11b+ Cd11c- monocytes/macrophages is elevated in the spleen
• 3 weeks after induction of cre expression by poly(I):poly(C) treatment, fraction of Cd11b+ Cd11c- monocytes/macrophages is elevated in the spleen
• 3 weeks after induction of cre expression by poly(I):poly(C) treatment, there is decreased splenic dendritic cell content

hematopoietic system
• 1 and 3 months after poly(I)-poly(C) injection, thymus size is reduced
• 1 month after poly(I)-poly(C) injection, the number of thymocytes is reduced and by 3 months the number of thymocytes is reduced to 1/8 that in control mice
• 1 and 3 months after poly(I)-poly(C) injection, in the thymus and bone marrow lymphocyte progenitors induce B cell development at the expense of T cell development; however myeloid and B cell lineage development in the bone marrow is normal
• after poly(I)-poly(C) injection, B cell development is impaired in the spleen but not in the bone marrow
• 1 and 3 months after poly(I)-poly(C) injection, a progressive increase in the number of double negative cells is seen in the thymus; however many of these cells are B cells
• 1 and 3 months after poly(I)-poly(C) injection, a progressive decrease in the number of double positive cells is seen in the thymus
• 1 and 3 months after poly(I)-poly(C) injection, T cell development is arrested at the CD44+CD25- pro-T cell or earlier stage (J:99747)
• 3 weeks after induction of cre expression by poly(I):poly(C) treatment, mice manifest a block in T cell development in the thymus (J:125869)
• 3 weeks after induction of cre expression by poly(I):poly(C) treatment, fraction of PDCs is elevated in the spleen
• 3 weeks after induction of cre expression by poly(I):poly(C) treatment, proportion of conventional Cd11chigh MHC class II+ dendritic cells is reduced 2.5 fold; decrease in the fraction of Cd11b+ dendritic cells corresponding to the CD8- subset is consistently observed
• one month after IFN-induced deletion, mutants show a gradual deletion of marginal zone B cells, from 10% to 3% of splenic B cells (J:76240)
• after poly(I)-poly(C) injection, marginal zone B cells are drastically reduced in spleen (J:99747)
• 1 and 3 months after poly(I)-poly(C) injection, a progressive increase in the number of B cells is seen in the thymus (J:99747)
• after poly(I)-poly(C) injection, pro-B and pre-B cell numbers are increased in the thymus (J:99747)
• 3 weeks after induction of cre expression by poly(I):poly(C) treatment, increased B cell development in the thymus is observed (J:125869)
• after poly(I)-poly(C) injection, follicular B cells are slightly increased in spleen
• 1 and 3 months after poly(I)-poly(C) injection, a progressive decrease in the number of single positive cells is seen in the thymus
• 3 weeks after induction of cre expression by poly(I):poly(C) treatment, fraction of Cd11b+ Cd11c- monocytes/macrophages is elevated in the spleen
• 3 weeks after induction of cre expression by poly(I):poly(C) treatment, fraction of Cd11b+ Cd11c- monocytes/macrophages is elevated in the spleen

endocrine/exocrine glands
• 1 and 3 months after poly(I)-poly(C) injection, thymus size is reduced
• 1 month after poly(I)-poly(C) injection, the number of thymocytes is reduced and by 3 months the number of thymocytes is reduced to 1/8 that in control mice




Genotype
MGI:3710554
cn20
Allelic
Composition
Cd19tm1(cre)Cgn/Cd19+
Rbpjtm1Hon/Rbpjtm1Hon
Spentm2.1Hon/Spentm2.1Hon
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd19tm1(cre)Cgn mutation (11 available); any Cd19 mutation (56 available)
Rbpjtm1Hon mutation (2 available); any Rbpj mutation (193 available)
Spentm2.1Hon mutation (3 available); any Spen mutation (140 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• severely decreased numbers of marginal zone B cells in spleen
• increased numbers of follicular B cells in spleen

hematopoietic system
• severely decreased numbers of marginal zone B cells in spleen
• increased numbers of follicular B cells in spleen




Genotype
MGI:3808716
cn21
Allelic
Composition
Rbpjtm1Hon/Rbpjtm1Hon
Mesp1tm2(cre)Ysa/Mesp1+
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mesp1tm2(cre)Ysa mutation (1 available); any Mesp1 mutation (17 available)
Rbpjtm1Hon mutation (2 available); any Rbpj mutation (193 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cardiovascular system
• valve formation is abnormal due to a lack of epithelial-mesenchymal transition and defective trabeculae
• trabecular layers are underdeveloped
• endocardial layers are abnormally detached from myocardial layers




Genotype
MGI:3844285
cn22
Allelic
Composition
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Cd4-cre)1Cwi/?
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * DBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rbpjtm1Hon mutation (2 available); any Rbpj mutation (193 available)
Tg(Cd4-cre)1Cwi mutation (10 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
• nave T cells fail to differentiate into the Th2 sub-type when co-cultured with LPS-treated DC from Myd88-null mice
• addition of IL-4 rescued this defect

immune system
• nave T cells fail to differentiate into the Th2 sub-type when co-cultured with LPS-treated DC from Myd88-null mice
• addition of IL-4 rescued this defect




Genotype
MGI:4889050
cn23
Allelic
Composition
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Lck-cre)19Hhan/0
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * DBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rbpjtm1Hon mutation (2 available); any Rbpj mutation (193 available)
Tg(Lck-cre)19Hhan mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
N
• mice show normal T cell development in the thymus and periphery
• engrafted mice show a nearly 2-fold increase in absolute number of T cells, while the B cell compartment is not different from wild-type
• in draining lymph nodes, a significant increase in CD4+ and CD8+ T cells is detected
• animals exhibit a significant increase in macrophage antigen-1-positive cells in spleens
• mice show 1.5-fold increase splenocyte number in engrafted mice
• skin and cardiac allografts from BALB/c mice to Rbpj-deficient mice show decreased survival time
• grafts of both tissue type show increased leukocyte infiltration
• percentage of proliferating CD4+ cells is significantly increased in lymph nodes and spleen; a similar increase in CD8+ T cells in spleen and lymph nodes is observed in engrafted animals
• suppression activity of CD4+CD25+ regulatory T cells is significantly attenuated in vitro; generation of Treg cells in vivo in graft recipients is not altered

hematopoietic system
• percentage of proliferating CD4+ cells is significantly increased in lymph nodes and spleen; a similar increase in CD8+ T cells in spleen and lymph nodes is observed in engrafted animals
• engrafted mice show a nearly 2-fold increase in absolute number of T cells, while the B cell compartment is not different from wild-type
• in draining lymph nodes, a significant increase in CD4+ and CD8+ T cells is detected
• animals exhibit a significant increase in macrophage antigen-1-positive cells in spleens
• mice show 1.5-fold increase splenocyte number in engrafted mice
• suppression activity of CD4+CD25+ regulatory T cells is significantly attenuated in vitro; generation of Treg cells in vivo in graft recipients is not altered

cellular
• percentage of proliferating CD4+ cells is significantly increased in lymph nodes and spleen; a similar increase in CD8+ T cells in spleen and lymph nodes is observed in engrafted animals




Genotype
MGI:3758749
cn24
Allelic
Composition
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Tyr-cre)2Lru/0
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * DBA/2
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rbpjtm1Hon mutation (2 available); any Rbpj mutation (193 available)
Tg(Tyr-cre)2Lru mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
pigmentation
N
• pigmentation mediated by non-follicular melanocytes such as in the ear or eye is not affected by this mutation
• almost complete hair whitening is observed

integument
• almost complete hair whitening is observed




Genotype
MGI:3758750
cn25
Allelic
Composition
Rbpjtm1Hon/Rbpj+
Tg(Tyr-cre)2Lru/0
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * DBA/2
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rbpjtm1Hon mutation (2 available); any Rbpj mutation (193 available)
Tg(Tyr-cre)2Lru mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
pigmentation
N
• loss of one allele has no affect on coat color; no graying or dilution is observed in 8-week old mice




Genotype
MGI:6267333
cn26
Allelic
Composition
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Tyr-cre)#Lru/0
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * DBA/2
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rbpjtm1Hon mutation (2 available); any Rbpj mutation (193 available)
Tg(Tyr-cre)#Lru mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype

The number of melanocyte lineage cells is dramatically reduced in Rbpjtm1Hon Rbpjtm1Hon Tg(Tyr-cre)#Lru/0 mice

pigmentation
• mice show a severe reduction of melanocytes (MCs) in hair follicles (HFs) at P4 and virtual loss of MCs in HFs at P32
• a reduction of MCs is noted in the hair matrix (HM) at P4; however, mature MCs are still retained in the HM at P12
• by P32, HFs lack both immature melanoblasts in the lower permanent portion (LPP) and differentiated MCs in the HM, indicating loss of the MSCs
• initial wave of melanogenesis during HF morphogenesis is severely impaired
• mice exhibit loss of hair pigmentation after the first hair molting
• at P4 and P18, mice exhibit severe coat-color dilution in the initial hairs
• at P18, hairs are a mixture of pigmented and unpigmented, whereas hairs from control mice are fully pigmented
• by P32 (subsequent hair cycle), almost all hairs grown in a shaved area are unpigmented
• a reduction of MCs is noted in the hair matrix (HM) at P4; however, mature MCs are still retained in the HM at P12
• mice show a severe reduction of melanocytes (MCs) in hair follicles (HFs) at P4 and virtual loss of MCs in HFs at P32
• by P32, HFs lack both immature melanoblasts in the lower permanent portion (LPP) and differentiated MCs in the HM, indicating loss of the MSCs

integument
• mice show a severe reduction of melanocytes (MCs) in hair follicles (HFs) at P4 and virtual loss of MCs in HFs at P32
• a reduction of MCs is noted in the hair matrix (HM) at P4; however, mature MCs are still retained in the HM at P12
• by P32, HFs lack both immature melanoblasts in the lower permanent portion (LPP) and differentiated MCs in the HM, indicating loss of the MSCs
• initial wave of melanogenesis during HF morphogenesis is severely impaired
• mice exhibit loss of hair pigmentation after the first hair molting
• at P4 and P18, mice exhibit severe coat-color dilution in the initial hairs
• at P18, hairs are a mixture of pigmented and unpigmented, whereas hairs from control mice are fully pigmented
• by P32 (subsequent hair cycle), almost all hairs grown in a shaved area are unpigmented

embryo
• whole-mount staining of dorsal skin epidermis using anti-c-Kit antibody revealed a significant reduction of melanoblast numbers at E16.5 and P0 relative to control mice
• at P4, some Dct+ melanoblasts are still detected in the lower permanent portion (LPP) of HFs; however, unlike in control mice, these are essentially lost by P12, indicating loss of melanocyte stem cells (MSCs)

nervous system
• whole-mount staining of dorsal skin epidermis using anti-c-Kit antibody revealed a significant reduction of melanoblast numbers at E16.5 and P0 relative to control mice
• at P4, some Dct+ melanoblasts are still detected in the lower permanent portion (LPP) of HFs; however, unlike in control mice, these are essentially lost by P12, indicating loss of melanocyte stem cells (MSCs)




Genotype
MGI:3767598
cn27
Allelic
Composition
Fbxw7tm1Kei/Fbxw7tm1Kei
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Cd4-cre)1Cwi/?
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * DBA/2
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fbxw7tm1Kei mutation (1 available); any Fbxw7 mutation (82 available)
Rbpjtm1Hon mutation (2 available); any Rbpj mutation (193 available)
Tg(Cd4-cre)1Cwi mutation (10 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• the number and percent of double positive thymocytes is increased compared to in wild-type mice

hematopoietic system
• the number and percent of double positive thymocytes is increased compared to in wild-type mice




Genotype
MGI:3603010
cn28
Allelic
Composition
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Vil1-cre/ERT2)23Syr/0
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * DBA/2
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rbpjtm1Hon mutation (2 available); any Rbpj mutation (193 available)
Tg(Vil1-cre/ERT2)23Syr mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
digestive/alimentary system
• 6 days after the last injection of tamoxifen (given for 5 consecutive days), in the small intestine and colon the rapidly dividing transit amplifying compartment is replaced by post-mitotic goblet cells, with almost complete conversion by 12 days

endocrine/exocrine glands
• 6 days after the last injection of tamoxifen (given for 5 consecutive days), in the small intestine and colon the rapidly dividing transit amplifying compartment is replaced by post-mitotic goblet cells, with almost complete conversion by 12 days




Genotype
MGI:5882984
cn29
Allelic
Composition
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Col1a1-cre)1Kry/0
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rbpjtm1Hon mutation (2 available); any Rbpj mutation (193 available)
Tg(Col1a1-cre)1Kry mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
skeleton
N
• mice do not exhibit an abnormal bone phenotype at 2 months of age




Genotype
MGI:3653205
cn30
Allelic
Composition
Rbpjtm1Hon/Rbpjtm1Hon
Tg(MMTV-cre)1Mam/0
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6J * FVB * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rbpjtm1Hon mutation (2 available); any Rbpj mutation (193 available)
Tg(MMTV-cre)1Mam mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
• at day 7 of pregnancy immature alveoli consist of round cells with radially positioned nuclei around the central lumen; cells are irregularly arranged with frequent gaps between them; also many of the lumina contained cellular debris
• on day 11, epithelia appears much sparser
• on day 13, clusters of disorganized cells with irregularly- shaped nuclei are seen and lipid droplets in the lumina are rare and proteinaceous material
• at term, an increase in disorganized cell clusters is seen, with the majority of cells having dark irregularly shaped nuclei surrounding small groups of cells with larger round nuclei
• a paucity of true luminal cells is found in mutant mammary glands during pregnancy
• when mutant mammary epithelium is transplanted into athymic nude mice from which the mammary tissue had been cleared for three generations, it is seen that there is restoration of normal ductal architecture after involution

reproductive system
• at day 7 of pregnancy immature alveoli consist of round cells with radially positioned nuclei around the central lumen; cells are irregularly arranged with frequent gaps between them; also many of the lumina contained cellular debris
• on day 11, epithelia appears much sparser
• on day 13, clusters of disorganized cells with irregularly- shaped nuclei are seen and lipid droplets in the lumina are rare and proteinaceous material
• at term, an increase in disorganized cell clusters is seen, with the majority of cells having dark irregularly shaped nuclei surrounding small groups of cells with larger round nuclei
• a paucity of true luminal cells is found in mutant mammary glands during pregnancy
• when mutant mammary epithelium is transplanted into athymic nude mice from which the mammary tissue had been cleared for three generations, it is seen that there is restoration of normal ductal architecture after involution

integument
• at day 7 of pregnancy immature alveoli consist of round cells with radially positioned nuclei around the central lumen; cells are irregularly arranged with frequent gaps between them; also many of the lumina contained cellular debris
• on day 11, epithelia appears much sparser
• on day 13, clusters of disorganized cells with irregularly- shaped nuclei are seen and lipid droplets in the lumina are rare and proteinaceous material
• at term, an increase in disorganized cell clusters is seen, with the majority of cells having dark irregularly shaped nuclei surrounding small groups of cells with larger round nuclei
• a paucity of true luminal cells is found in mutant mammary glands during pregnancy
• when mutant mammary epithelium is transplanted into athymic nude mice from which the mammary tissue had been cleared for three generations, it is seen that there is restoration of normal ductal architecture after involution
• cysts containing abundant whorls of keratin are observed
• mutant skin display hyperkeratinization

growth/size/body
• cysts containing abundant whorls of keratin are observed




Genotype
MGI:4441397
cn31
Allelic
Composition
Nr2f2tm2.1Tsa/Nr2f2tm2.1Tsa
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Tek-cre)1Ywa/0
Genetic
Background
involves: 129S1/Sv * 129S7/SvEvBrd * C57BL/6 * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Nr2f2tm2.1Tsa mutation (0 available); any Nr2f2 mutation (27 available)
Rbpjtm1Hon mutation (2 available); any Rbpj mutation (193 available)
Tg(Tek-cre)1Ywa mutation (6 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• fewer embryos than expected are found at E10.0

immune system
• at E10.0, number of Prox1+ve lymphatic endothelial cells is dramatically reduced




Genotype
MGI:4441396
cn32
Allelic
Composition
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Tek-cre)1Ywa/0
Genetic
Background
involves: 129S7/SvEvBrd * C57BL/6 * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rbpjtm1Hon mutation (2 available); any Rbpj mutation (193 available)
Tg(Tek-cre)1Ywa mutation (6 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• fewer embryos than expected are found at E10.0





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
03/19/2024
MGI 6.23
The Jackson Laboratory